Amsterdam, 24-25 Mai 2002: „Fifth FIAPAC-Conference“

• Freitag, 24. Mai
• Samstag, 25. Mai

• 09:00-
  10:30
  Medikamentöser Abbruch -Neue Entwicklungen Medikamentöser Abbruch -Neue Entwicklungen

  Chair:

  • Elisabeth Aubény, FR
  • Kristina Gemzell-Danielsson, SE

  • Diskussion
  • Medikamentöser Abbruch zwischen 9-14 Woche - Pak Chung Ho, CN
  • Einnahme des Prostaglandins zu Hause - Isabelle Dagousset, FR
  • Misoprostol: Verschiedene Arten der Einnahme - Kristina Gemzell-Danielsson, SE

• 10:30-
  11:00
  Kaffepause

• 11:00-
  12:00
  Arbeitskreise Abbruch in Entwicklungsländern

  Chair:

  • Marijke Alblas, ZA

  • Die Liberalisierung des Abbruchs in Südafrika - Marie Adamo, ZA
  • Die Einstellung von Frauenärzten in Argentinien zum Abbruch - Silvina Ramos, AR

  Abbruch im zweiten Trimester

  Chair:

  • Thea Schipper, NL

  • ƒ Medikamentös mit Mifepriston - Kristina Gemzell-Danielsson, SE
  • Die chirurgische Methode - Santiago Barambio, ES

  Medikamente während und nach einem medikamentösen Abbruch

  Chair:

  • Mirella Parachini, IT

  • Antibiotika, Schmerzbehandlung - Penney Gillian, GB
  • Nicht-steroidale Antiphlogistika in der Schmerzbehandlung, Rh-immunoglobulingabe - Christian Fiala, AT
    

    Abstract and more Information

    • Author Christian Fiala, AT (all speeches)
    • Contact christian.fiala@aon.at ,http://www.gynmed.at

    Medication After Medical Abortion -

    NSAIDs in pain treatment, Rh-immunoglobulin

     

    Christian Fiala

     

    Management of pain during medical abortion has been hampered by recommendations in the product information and guidelines from various sources that non-steroidal anti-inflammatory drugs (NSAIDS) should not be given to women at least until the follow-up visit eight to 12 days after mifepristone administration. Currently the summary of product characteristics for mifepristone includes advice that, ‘A decrease of the efficacy of the method can theoretically occur due to the antiprostaglandin properties of NSAIDS. Use preferably non-NSAI agents.’ The published evidence does not support these recommendations against the use of NSAIDs.

    Furtheromore NSAIDS are prostaglandin synthetase inhibitors and should have no adverse effect on exogenous prostaglandins. Stated alternatively, NSAIDs don't interfere with misoprostol and there are some good arguments for their use.

    The efficacy of medical abortion in Karolinska Institute and in the General Public Hospital in Korneuburg/Austria has been the same when NSAIDS are used

     

    Anti-D immune globulin is given in most places after early abortion, although evidence is lacking for the usefulness of this intervention at this early stage of pregnancy. Evidence-based guidelines for the administration of anti-D immune globulin (anti-D IgG) for women undergoing early spontaneous or induced abortions are missing. This is especially true for medical abortion, which is increasingly used in recent years.

    An ongoing study in Sweden is presented.

  Begleitung durch den Partner

  Chair:

  • Dominique Roynet, BE

  • Erfahrungen aus der Schweiz - Angelika Schwendke, CH
  • Erhahrungen aus Italien - Mirella Parachini, IT

• 12:00-
  14:00
  Mittagessen

• 14:00-
  15:30
  Verhütung und Sexualität nach einem Abbruch Verhütung und Sexualität nach einem Abbruch

  Chair:

  • Philippe Lefèbvre, FR
  • Mirella Parachini, IT

  • Beratung - Jim McVicker, GB
  • Diskussion
  • Methoden - Viveca Odlind, SE
  • Sexualität nach einem Abbruch - Kristina Hänel-Groh, DE

• 15:30-
  16:00
  Kaffepause

• 16:00-
  17:00
  Illegale Abbrüche? Illegale Abbrüche?

  Chair:

  • Elisabeth Aubény, FR
  • Vicki Saporta, US

  • Diskussion
  • Warum gibt es immer noch illegale Abbrüch - Rebecca Cook, CA
  • Pourquoi y a-t-il toujours des grossesses non désirées - Natalie Bajos, FR

• 17:00-
  
  Schlussveranstaltung

• Freitag, 24. Mai
• Samstag, 25. Mai